Elevated levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and neuron-specific enolase (NSE) have been linked to unfavorable outcomes following AIS [11,12]. The gene discussed is ENO2; the disease is androgen insensitivity syndrome.